Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Juan Ignacio Delgado Mingorance | Researchclopedia

Back to researchers

Juan Ignacio Delgado Mingorance

12

Works

3,287

Citations

7

h-index

6

i10-index

Research Topics

Cancer Treatment and Pharmacology HER2/EGFR in Cancer Research Advanced Breast Cancer Therapies

Affiliations

Centro de Implantología Cirugía Oral y Maxilofacial2021–2021

Hospital Universitario Infanta Cristina2015–2023

Top Works

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Jonathan W. Goldman,Mikhail Dvorkin,et al.

2020668 citations

Cancer Cells and Metastasis

Neuroendocrine Tumor Research Advances

Patient-Reported Outcomes in Patients With <i>PIK3CA</i>-Mutated Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer From SOLAR-1

Eva Ciruelos,Hope S. Rugo,et al.

202134 citations

Darolutamide Maintenance in Patients With Metastatic Castration-Resistant Prostate Cancer With Nonprogressive Disease After Taxane Treatment (SAKK 08/16)

Silke Gillessen,Giuseppe Procopio,et al.

202310 citations

Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study

Luís Manso,Fernando Moreno Antón,et al.

20199 citations

Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial

Javier Salvador Bofill,Fernando Moreno Antón,et al.

20226 citations

Cobimetinib (C) + paclitaxel (P) as first-line treatment in patients (pts) with advanced triple-negative breast cancer (TNBC): Updated results and biomarker data from the phase 2 COLET study.

Adam Brufsky,Sung‐Bae Kim,et al.

20166 citations

Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: BIBABRAX study.

Jaime Feliú Batlle,Mónica Jorge Fernández,et al.

20203 citations

Alpelisib (ALP) with fulvestrant (FUL) in patients (pts) with <i>PIK3CA-</i>mutated hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2-) advanced breast cancer (ABC): Primary or secondary resistance to prior endocrine therapy (ET) in the SOLAR-1 trial.

Dejan Juric,Sibylle Loibl,et al.

20191 citations

Circulating tumor cells (CTCs) in patients with HER2-negative recurrent or metastatic breast cancer treated with eribulin as third-line therapy: ONSITE trial (OncoSur Analysis of the Treatment in Third Line of ABC with Eribulin).

Luís Manso,Fernando Moreno,et al.

20150 citations